Starvation-inactivated MTOR triggers cell migration via a ULK1-SH3PXD2A/TKS5-MMP14 pathway in ovarian carcinoma

Autophagy. 2023 Dec;19(12):3151-3168. doi: 10.1080/15548627.2023.2239633. Epub 2023 Jul 28.

Abstract

AMPK: AMP-activated protein kinase; CHX: cycloheximide; RAD001: everolimus; HBSS: Hanks' balanced salt solution; LC-MS/MS: liquid chromatography-mass spectrometry/mass spectrometry; MMP14: matrix metallopeptidase 14; MTOR: mechanistic target of rapamycin kinase; MAPK: mitogen-activated protein kinase; RB1CC1/FIP200: RB1 inducible coiled-coil 1; PtdIns3P: phosphatidylinositol-3-phosphate; PX: phox homology; SH3: Src homology 3; SH3PXD2A/TKS5: SH3 and PX domains 2A; SH3PXD2A-[6A]: S112A S142A S146A S147A S175A S348A mutant; ULK1: unc-51 like autophagy activating kinase 1.

Keywords: MMP14; SH3PXD2A; ULK1; cellular migration; ovarian cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Adaptor Proteins, Vesicular Transport
  • Autophagy*
  • Autophagy-Related Protein-1 Homolog / metabolism
  • Cell Movement
  • Chromatography, Liquid
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Matrix Metalloproteinase 14
  • Ovarian Neoplasms*
  • TOR Serine-Threonine Kinases / metabolism
  • Tandem Mass Spectrometry

Substances

  • Matrix Metalloproteinase 14
  • AMP-Activated Protein Kinases
  • TOR Serine-Threonine Kinases
  • Adaptor Proteins, Vesicular Transport
  • Autophagy-Related Protein-1 Homolog
  • MMP14 protein, human
  • MTOR protein, human
  • SH3PXD2A protein, human
  • ULK1 protein, human
  • Intracellular Signaling Peptides and Proteins

Grants and funding

This study was financially supported by grants from the National Science and Technology Council, Taiwan (111-2314-B-182A-035-MY3 to CLT; 110-2314-B-182-033 to CNT; 111-2314-B-182A-088 to CYL) and Chang Gung Medical Research Foundation, Taiwan (CMRPG3L1431, CMRPG3M0801, and CMRPG3M1291 to CLT, CMRPG3M0761 to CYL).